Prevalence of pulmonary hypertension in obstructive sleep apnea and its relation to disease severity

Ian Milligan1,2, Anna Kate Shaw1,2, Roberta Leu1,3

  • 1Children's Healthcare of Atlanta, Atlanta, Georgia.

Insights

Pulmonary hypertension (PHTN) was found in 4.3% of children with obstructive sleep apnea (OSA). PHTN in children with OSA was linked to comorbidities like bronchopulmonary dysplasia, not OSA severity.

Area of Science:

  • Pediatric Cardiology
  • Sleep Medicine
  • Respiratory Medicine

Background:

  • Obstructive sleep apnea (OSA) is a common condition in children.
  • Pulmonary hypertension (PHTN) is a serious complication that can arise from various conditions.
  • The relationship between OSA severity and PHTN in pediatric populations requires further investigation.

Purpose of the Study:

  • To determine the prevalence of PHTN in children diagnosed with OSA.
  • To assess echocardiographic (ECHO) findings indicative of PHTN in this cohort.
  • To explore the correlation between PHTN and the severity of OSA, including hypoxemia and hypercarbia.

Main Methods:

  • Retrospective cohort study of pediatric patients with OSA.
  • Inclusion criteria: polysomnogram and ECHO within 30 days, absence of cardiac disease.
  • PHTN definition based on specific ECHO parameters; comparison with OSA severity metrics (apnea-hypopnea index, oxygen saturation, end-tidal carbon dioxide).

Main Results:

  • Echocardiographic evidence of PHTN was identified in 4.3% of the 509 patients studied.
  • No significant correlation was found between OSA severity (apnea-hypopnea index, hypoxemia, hypercarbia) and ECHO parameters of PHTN.
  • Comorbidities such as bronchopulmonary dysplasia (OR 5.22), prematurity (OR 3.10), and autism (OR 3.69) were associated with increased odds of PHTN.

Conclusions:

  • A notable percentage of children with OSA exhibit echocardiographic signs of PHTN.
  • OSA severity, based on polysomnogram data, does not appear to be a direct predictor of PHTN in this population.
  • Bronchopulmonary dysplasia, prematurity, and autism are identified as significant risk factors for developing PHTN in children with OSA.
Abstract

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
159
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
188
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
844
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
225
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K